ENLIVEN THERAPEUTICS, INC. Shares Outstanding (Cover Page)
ENLIVEN THERAPEUTICS, INC. (ELVN) had Shares Outstanding (Cover Page) of 73.27 million shares as of 2026-07-28, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-28: Entity Common Stock, Shares Outstanding 73.27M shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 60.90M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 59.80M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 59.35M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 73.27M shares 10-Q · filed 2026-08-05 |
| 2026-04-28 | 60.90M shares 10-Q · filed 2026-05-07 |
| 2026-02-19 | 59.80M shares 10-K · filed 2026-03-03 |
| 2025-10-31 | 59.35M shares 10-Q · filed 2025-11-12 |
| 2025-07-31 | 59.24M shares 10-Q · filed 2025-08-13 |
| 2025-05-01 | 49.07M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 49.00M shares 10-K · filed 2025-03-13 |
| 2024-11-01 | 48.86M shares 10-Q · filed 2024-11-13 |
| 2024-08-01 | 47.24M shares 10-Q · filed 2024-08-13 |
| 2024-05-01 | 47.04M shares 10-Q · filed 2024-05-14 |
| 2024-03-01 | 41.35M shares 10-K · filed 2024-03-14 |
| 2023-11-01 | 41.21M shares 10-Q · filed 2023-11-09 |
| 2023-08-01 | 41.15M shares 10-Q · filed 2023-08-10 |
| 2023-05-01 | 41.11M shares 10-Q · filed 2023-05-11 |
| 2023-02-06 | 26.23M shares 10-K · filed 2023-02-10 |
| 2022-10-20 | 26.29M shares 10-Q · filed 2022-10-25 |
| 2022-08-01 | 26.29M shares 10-Q · filed 2022-08-03 |
| 2022-04-30 | 26.28M shares 10-Q · filed 2022-05-06 |
| 2022-03-01 | 26.29M shares 10-K · filed 2022-03-15 |
| 2021-10-29 | 26.28M shares 10-Q · filed 2021-11-09 |
| 2021-08-02 | 26.25M shares 10-Q · filed 2021-08-06 |
| 2021-05-06 | 17.64M shares 10-Q · filed 2021-05-11 |
| 2021-03-01 | 17.58M shares 10-K · filed 2021-03-05 |
| 2020-10-30 | 17.41M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 17.32M shares 10-Q · filed 2020-08-14 |
| 2020-05-01 | 17.28M shares 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |